A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China.
Clinical trial NCT03597919 · COMPLETED
Trial details
- NCT number
- NCT03597919
- Sponsor
- Centers for Disease Control and Prevention, China
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2019-09-30
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.